Enzon Pharmaceuticals, Inc. SWOT company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.
Enzon Pharmaceuticals (Enzon) is a biopharmaceutical company engaged in the development and commercialization of therapeutics to treat cancer and life-threatening diseases. It's portfolio includes Oncaspar, DepoCyt, Abelcet and Adagen. Enzon also engages in contract manufacturing for several pharmaceutical companies. The company primarily operates in the US and Europe. It is headquartered in Bridgewater, New Jersey and employs about 400 people. The company recorded revenues of $185.7 million during the fiscal year ended December 2006. The operating profit of the company during fiscal year 2006 was $10.5 million. The net profit was $21.3 million in fiscal year 2006. 10K - 74
Scope of the Report
- Provides all the crucial company information required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting the company in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams
- Data is supplemented with details on the company’s history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement
Reasons to Purchase
- Support sales activities by understanding your customers’ businesses better
- Qualify prospective partners and suppliers
- Keep fully up to date on your competitors’
- Obtain the most up to date company information availablehttp://www.companiesandmarkets.com/
